185613-71-2 ((8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one,(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one)

CAS号:
185613-71-2
中文名称:
(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one
英文名称:
(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one
分子式:
C22H29FO5
分子量:
392.461070775986

(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-71-2)名称与标识符

名称

中文别名:
(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one;
英文别名:
(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one;D5P9N1W189;DTXCID0094287;UNII-D5P9N1W189;Q27276125;Betamethasone impurity H;9-Desfluoro-14-fluoro Betamethasone;DTXSID70171796;185613-71-2;14-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYL-8.ALPHA.,9.BETA.,14.BETA.-PREGNA-1,4-DIENE-3,20-DIONE;BETAMETHASONE IMPURITY H [EP IMPURITY];Betamethasone impurity H [EP];BETAMETHASONE IMPURITY H (EP IMPURITY);(8alpha,9beta,11beta,14beta,16beta)-14-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;PREGNA-1,4-DIENE-3,20-DIONE, 14-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-, (8.ALPHA.,9.BETA.,11.BETA.,14.BETA.,16.BETA.)-;14-Fluoro-11beta,17,21-trihydroxy-16beta-methyl-8alpha,9beta,14beta-pregna-1,4-diene-3,20-dione;Pregna-1,4-diene-3,20-dione, 14-fluoro-11,17,21-trihydroxy-16-methyl-, (8alpha,9beta,11beta,14beta,16beta)-;

标识符

InChIKey:
OXYIPQGDQCLIAE-RNGLRLRGSA-N
Inchi:
1S/C22H29FO5/c1-12-9-21(23)15-5-4-13-8-14(25)6-7-19(13,2)18(15)16(26)10-20(21,3)22(12,28)17(27)11-24/h6-8,12,15-16,18,24,26,28H,4-5,9-11H2,1-3H3/t12-,15-,16-,18-,19-,20-,21-,22-/m0/s1
SMILES:
F[C@]12C[C@H](C)[C@](C(CO)=O)([C@@]1(C)C[C@@H]([C@H]1[C@]3(C=CC(C=C3CC[C@H]21)=O)C)O)O

(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-71-2)物化性质

计算特性

  • 精确分子量 : 392.19990218Da
  • 氢键供体数量 : 3
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 2
  • 同位素质量 : 392.19990218Da
  • 重原子数量 : 28
  • 复杂度 : 805
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 8
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2
  • 拓扑分子极性表面积 : 94.8Ų

(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one(185613-71-2)推荐厂家 更多厂家(6)

公司名称手机号/电话联系人QQ微信询单
深圳菲斯生物科技有限公司 18925202235周美娇 2850179284
询单
湖北扬信医药科技有限公司 18071854684
0714-3999001
程舒畅 2885409691
询单
湖北瑞诺医药科技有限公司 13165688766汪经理 3008058303
询单
深圳振强药物研发有限公司 13670046396
86-755-66853366
颜经理 2851296953
询单
上海柯维化学技术有限公司 18901607656
021-64609169
白荷 3428632096 询单
南兴化工(江苏)有限公司 18651116180
0512-66387035
闵慧萍 3771156959 询单